Adamis: 2Q Earnings Snapshot
SAN DIEGO (AP) _ Adamis Pharmaceuticals Corp. (ADMP) on Friday reported a loss of $9.7 million in its second quarter.
On a per-share basis, the San Diego-based company said it had a loss of 29 cents.
The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 17 cents per share.
The biopharmaceutical company posted revenue of $3.9 million in the period, which also missed Street forecasts. Three analysts surveyed by Zacks expected $4.1 million.
The company’s shares closed at $3.25. A year ago, they were trading at $4.55.